Tag: UCB
Hope for chronic arthritis patients
Pharma major UCB has announced the European Commission approval for Bimzelx (bimekizumab), its humanized monoclonal IgG1 antibody. Bimzelx is said to exert simultaneous selective...
Gea’s Talking Pharma Chat Show
Earlier this year, continuous manufacturing pioneers Gea Pharma and Healthcare launched a new, interactive, and upbeat series of roundtable conversations for industry professionals. The...